EUVIMEDEUVIMED entdecken
Crossref

Gut-lung axis in neonatal respiratory distress syndrome: integrated evidence from pharmacovigilance and Mendelian randomization

Journal of Chinese Pharmaceutical Sciences · 30.07.2026 · 35 (7) · 643

DOI: 10.5246/jcps.2026.07.046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chinese Pharmaceutical Sciences, online erschienen am 10.07.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Gut-lung axis in neonatal respiratory distress syndrome: integrated evidence from pharmacovigilance and Mendelian randomization. Journal of Chinese Pharmaceutical Sciences, 35(7), 643. https://doi.org/10.5246/jcps.2026.07.046

Vancouver

Gut-lung axis in neonatal respiratory distress syndrome: integrated evidence from pharmacovigilance and Mendelian randomization. Journal of Chinese Pharmaceutical Sciences. 2026;35(7):643. doi:10.5246/jcps.2026.07.046

BibTeX
@article{euvimed2026,
  title = {Gut-lung axis in neonatal respiratory distress syndrome: integrated evidence from pharmacovigilance and Mendelian randomization},
  journal = {Journal of Chinese Pharmaceutical Sciences},
  year = {2026},
  volume = {35},
  number = {7},
  pages = {643},
  doi = {10.5246/jcps.2026.07.046}
}
Kostenlos starten →